Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1679

1.

Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.

Maule M, Scélo G, Pastore G, Brennan P, Hemminki K, Tracey E, Sankila R, Weiderpass E, Olsen JH, McBride ML, Brewster DH, Pompe-Kirn V, Kliewer EV, Chia KS, Tonita JM, Martos C, Jonasson JG, Merletti F, Boffetta P.

J Natl Cancer Inst. 2007 May 16;99(10):790-800.

2.

Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.

MacArthur AC, Spinelli JJ, Rogers PC, Goddard KJ, Phillips N, McBride ML.

Pediatr Blood Cancer. 2007 Apr;48(4):453-9.

PMID:
16767718
3.

Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.

Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.

Arch Dermatol. 2007 Jan;143(1):45-50.

PMID:
17224541
4.

Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study.

Maule M, Scélo G, Pastore G, Brennan P, Hemminki K, Pukkala E, Weiderpass E, Olsen JH, Tracey E, McBride ML, Brewster DH, Pompe-Kirn V, Tonita JM, Kliewer EV, Chia KS, Jonasson JG, Martos C, Magnani C, Boffetta P.

Eur J Cancer. 2008 Apr;44(6):830-9. doi: 10.1016/j.ejca.2008.02.012. Epub 2008 Mar 10.

PMID:
18329873
5.

Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study.

Frisch M, Hjalgrim H, Olsen JH, Melbye M.

Ann Intern Med. 1996 Nov 15;125(10):815-21.

PMID:
8928988
6.

Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.

Olsen JH, Möller T, Anderson H, Langmark F, Sankila R, Tryggvadóttír L, Winther JF, Rechnitzer C, Jonmundsson G, Christensen J, Garwicz S.

J Natl Cancer Inst. 2009 Jun 3;101(11):806-13. doi: 10.1093/jnci/djp104. Epub 2009 May 26.

PMID:
19470947
7.

Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.

Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE.

J Natl Cancer Inst. 2008 Dec 17;100(24):1771-9. doi: 10.1093/jnci/djn394. Epub 2008 Dec 9.

PMID:
19066271
8.

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort.

J Natl Cancer Inst. 2005 Mar 16;97(6):425-32.

PMID:
15770006
9.

Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.

Bhatia S, Sather HN, Pabustan OB, Trigg ME, Gaynon PS, Robison LL.

Blood. 2002 Jun 15;99(12):4257-64.

10.

Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.

Moser EC, Noordijk EM, van Leeuwen FE, Baars JW, Thomas J, Carde P, Meerwaldt JH, van Glabbeke M, Kluin-Nelemans HC.

Haematologica. 2006 Nov;91(11):1481-8. Epub 2006 Oct 17.

11.

Merkel cell carcinoma: incidence, mortality, and risk of other cancers.

Kaae J, Hansen AV, Biggar RJ, Boyd HA, Moore PS, Wohlfahrt J, Melbye M.

J Natl Cancer Inst. 2010 Jun 2;102(11):793-801. doi: 10.1093/jnci/djq120. Epub 2010 Apr 27.

PMID:
20424236
12.

Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.

Spanogle JP, Clarke CA, Aroner S, Swetter SM.

J Am Acad Dermatol. 2010 May;62(5):757-67. doi: 10.1016/j.jaad.2009.07.039. Epub 2010 Mar 12.

PMID:
20223559
13.

Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.

Tuohimaa P, Pukkala E, Scélo G, Olsen JH, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Kliewer EV, Pompe-Kirn V, McBride ML, Martos C, Chia KS, Tonita JM, Jonasson JG, Boffetta P, Brennan P.

Eur J Cancer. 2007 Jul;43(11):1701-12. Epub 2007 May 30.

PMID:
17540555
14.

Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study.

Henderson TO, Whitton J, Stovall M, Mertens AC, Mitby P, Friedman D, Strong LC, Hammond S, Neglia JP, Meadows AT, Robison L, Diller L.

J Natl Cancer Inst. 2007 Feb 21;99(4):300-8.

PMID:
17312307
15.

Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, Ronckers CM, Friedman DL, Stovall M, Yasui YY, Robison LL, Meadows AT, Kadan-Lottick NS.

J Clin Oncol. 2006 Jan 20;24(3):476-83.

PMID:
16421424
16.

Italian cancer figures, report 2013: Multiple tumours.

AIRTUM Working Group.

Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152. English, Italian.

17.

Cancer incidence in the rural community of Tecumseh, Michigan: a pattern of increased lymphopoietic neoplasms.

Waterhouse D, Carman WJ, Schottenfeld D, Gridley G, McLean S.

Cancer. 1996 Feb 15;77(4):763-70.

18.

Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.

Hisada M, Chen BE, Jaffe ES, Travis LB.

J Natl Cancer Inst. 2007 Feb 7;99(3):215-22.

PMID:
17284716
19.

Second malignant neoplasms following childhood cancer: a study of a recent cohort (1987-2004) from the childhood cancer registry of the Rhône-Alpes region (ARCERRA) in France.

Berger C, Trombert-Paviot B, Casagranda L, Mialou V, Frappaz D, Plantaz D, Collardeau-Frachon S, Freycon F.

Pediatr Hematol Oncol. 2011 Aug;28(5):364-79. doi: 10.3109/08880018.2011.562601.

PMID:
21736475
20.

The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries).

Crocetti E, Guzzinati S, Paci E, Falcini F, Zanetti R, Vercelli M, Rashid I, De Lisi V, Russo A, Vitarelli S, Ferretti S, Mangone L, Cesaraccio R, Tumino R, Pannozzo F.

Melanoma Res. 2008 Jun;18(3):230-4. doi: 10.1097/CMR.0b013e3282fafd0a.

PMID:
18477899

Supplemental Content

Support Center